Healthcare

Senruis Biotechnology (Shenzhen) Co., Ltd. was established in 2019 and is an international high-tech company engaged in research and development as well as production in the field of synthetic biology.

Signor Biotech was founded by a research team from Tsinghua University, combining cutting-edge medical and engineering technologies to highly restore the physiological state of maternal tissues and form "micro organs" (i.e. organoids) composed of multiple cell types.

Shenzhen Boya Gene Technology Co., Ltd. is a biotechnology startup focused on the research and clinical translation of gene therapy drugs, with a focus on chronic diseases and functional degenerative diseases that seriously affect the health of a large number of elderly people. Our gene drug uses adenovirus associated virus (AAV) as a delivery technology.

Shengbao Biotechnology Co., Ltd. was established in 2023 and is headquartered in Shenzhen, China. The company is committed to developing innovative live bacterial drugs, utilizing gene circuits and precise regulation of gene and payload expression to meet the treatment needs of various types of diseases.

Shenzhen Pruqi Biotechnology Co., Ltd. (referred to as "Pruqi Biotechnology") was established in 2024 and is an innovative biotechnology enterprise focusing on the field of pet health. Its headquarters is located in Guangming District, Shenzhen. Our mission is to empower pet health through technological innovation, and we are committed to becoming a leader in the field of pet bioproducts.